{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PBO", "query": { "intervention": "PBO" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 166, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PBO&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-05T07:55:23.265Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00782509", "title": "12 / 48 wk Pivotal PFT vs PBO in COPD II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol (BI 1744)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 644, "start_date": "2009-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 28, "location_summary": "Mobile, Alabama • Wheat Ridge, Colorado • Waterbury, Connecticut + 23 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782509" }, { "nct_id": "NCT00261443", "title": "A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium or Valproate with placebo (PBO)", "type": "DRUG" }, { "name": "Lithium or Valproate with Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1270, "start_date": "2005-09", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2023-04-18", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 29, "location_summary": "Tuscaloosa, Alabama • Anaheim, California • Cerritos, California + 24 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00261443" }, { "nct_id": "NCT03895203", "title": "A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Bimekizumab", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 852, "start_date": "2019-04-03", "completion_date": "2022-07-11", "has_results": true, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 25, "location_summary": "Phoenix, Arizona • San Diego, California • Tustin, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Palm Harbor", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03895203" }, { "nct_id": "NCT05004987", "title": "Aβ Dynamics in LLMD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alzheimer Disease", "Major Depressive Disorder" ], "interventions": [ { "name": "Escitalopram Oxalate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 60, "start_date": "2022-02-04", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 2, "location_summary": "New York, New York • Orangeburg, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Orangeburg", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05004987" }, { "nct_id": "NCT03928743", "title": "A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Bimekizumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 332, "start_date": "2019-04-25", "completion_date": "2022-08-08", "has_results": true, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 14, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Sun City, Arizona + 10 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03928743" }, { "nct_id": "NCT00357994", "title": "Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Parkinson's Disease" ], "interventions": [ { "name": "Levodopa carbidopa intestinal gel (LCIG)", "type": "DRUG" }, { "name": "Placebo gel", "type": "DRUG" }, { "name": "Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets", "type": "DRUG" }, { "name": "Placebo (PBO) oral capsules", "type": "DRUG" }, { "name": "CADD-Legacy® 1400 ambulatory infusion pump", "type": "DEVICE" }, { "name": "PEG tube", "type": "DEVICE" }, { "name": "J-tube", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 36, "start_date": "2009-01", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2015-01-16", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 8, "location_summary": "Los Angeles, California • Englewood, Colorado • Washington D.C., District of Columbia + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00357994" }, { "nct_id": "NCT05855369", "title": "Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Smell Dysfunction", "Olfactory Disorder", "Long COVID" ], "interventions": [ { "name": "Trigeminal Nerve Stimulation (TNS)", "type": "DEVICE" }, { "name": "Active Smell Training (ST)", "type": "OTHER" }, { "name": "Placebo Smell Training (PBO)", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 145, "start_date": "2023-10-02", "completion_date": "2028-05-31", "has_results": false, "last_update_posted_date": "2026-04-02", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05855369" }, { "nct_id": "NCT00613379", "title": "PRO 140 by IV Administration in Adults With HIV-1 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "PRO 140", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CytoDyn, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2007-12", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2016-07-15", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 1, "location_summary": "Tarrytown, New York", "locations": [ { "city": "Tarrytown", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00613379" }, { "nct_id": "NCT02338960", "title": "2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypoactive Sexual Desire Disorder" ], "interventions": [ { "name": "Bremelanotide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palatin Technologies, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 714, "start_date": "2015-01", "completion_date": "2017-06-29", "has_results": true, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02338960" }, { "nct_id": "NCT03247530", "title": "Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "100mg SPN-812", "type": "DRUG" }, { "name": "200mg SPN-812", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Supernus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 477, "start_date": "2017-10-20", "completion_date": "2018-09-12", "has_results": true, "last_update_posted_date": "2021-07-02", "last_synced_at": "2026-09-05T07:55:23.265Z", "location_count": 7, "location_summary": "Dothan, Alabama • Hialeah, Florida • Meridian, Idaho + 4 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Rochester", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03247530" } ] }